CGON
CG Oncology, Inc.
68.80$
-6.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -88.9% | +52,800.0% | -79.0% | -61.3% | +960.5% | -88.6% | -100.0% | – | +39.4% | -53.4% | +6.8% | – | |
| – | -100.0% | +0.0% | +461,650.0% | +6.2% | +36.6% | +2.5% | +14.1% | -95.0% | +84.8% | +1.6% | +32.5% | – | |
| – | – | – | -3,597.0% | – | – | – | – | – | -765.2% | – | – | – | |
| – | +35.6% | +8.1% | +7.3% | +6.2% | +36.6% | +2.5% | +14.1% | -11.0% | +7.4% | +46.0% | +25.0% | – | |
| – | +30.3% | +91.8% | +29.5% | +16.3% | +34.3% | +26.3% | +17.7% | +34.0% | -22.9% | +15.5% | +39.4% | – | |
| – | +717.0% | +21.5% | -67.4% | +16.3% | +34.3% | +26.3% | +17.7% | +194.2% | -6.1% | +34.1% | +29.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.